|1||NCT02571894||Active, not recruiting||The Cardio-Oncology Breast Cancer Study||
||320||Female||18 Years and older (Adult, Older Adult)||NCT02571894||COBC||COBC||July 2014||February 2020||February 2020||October 8, 2015||March 7, 2018||
|Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer||
||Industry / Other||
||5099||Female||18 Years and older (Adult, Older Adult)||NCT00045032||BO16348
|HERA||November 2001||March 2005||June 2015||January 27, 2003||April 27, 2017||April 27, 2017||
† Study has passed its completion date and status has not been verified in more than two years.